We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWY icon
1576
iShares Russell Top 200 Growth ETF
IWY
$16.6B
$2.8M ﹤0.01%
32,653
+3,874
+13% +$326K
BGR icon
1577
BlackRock Energy and Resources Trust
BGR
$420M
$2.79M ﹤0.01%
234,089
-4,628
-2% -$54.8K
WCC
1578
WESCO International
WCC
$18B
$2.79M ﹤0.01%
54,989
+8,545
+18% +$447K
WWD icon
1579
Woodward
WWD
$21B
$2.78M ﹤0.01%
24,539
-2,619
-10% -$281K
HP icon
1580
Helmerich & Payne
HP
$4.16B
$2.77M ﹤0.01%
54,822
-4,160
-7% -$229K
CTBI icon
1581
Community Trust Bancorp
CTBI
$1.4B
$2.77M ﹤0.01%
65,594
+1,398
+2% +$58K
KIE icon
1582
State Street SPDR S&P Insurance ETF
KIE
$679M
$2.77M ﹤0.01%
81,527
+36,797
+82% +$1.21M
SRPT icon
1583
Sarepta Therapeutics
SRPT
$1.79B
$2.77M ﹤0.01%
18,233
+628
+4% +$76.3K
VKTX icon
1584
Viking Therapeutics
VKTX
$3.98B
$2.77M ﹤0.01%
333,073
+3,347
+1% +$28.6K
CNH
1585
CNH Industrial
CNH
$16.9B
$2.77M ﹤0.01%
309,320
+94,217
+44% +$820K
APO icon
1586
Apollo Global Management
APO
$75.7B
$2.76M ﹤0.01%
80,371
+15,888
+25% +$505K
DAR icon
1587
Darling Ingredients
DAR
$10B
$2.76M ﹤0.01%
138,581
-124,676
-47% -$2.56M
MGA icon
1588
Magna International
MGA
$18.8B
$2.75M ﹤0.01%
55,502
-29,888
-35% -$1.48M
PCH
1589
DELISTED
PotlatchDeltic
PCH
$2.75M ﹤0.01%
70,557
+1,554
+2% +$58.4K
AEM icon
1590
Agnico Eagle Mines
AEM
$91.3B
$2.75M ﹤0.01%
53,707
+13,320
+33% +$581K
CTT
1591
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$2.75M ﹤0.01%
262,776
-56,117
-18% -$558K
TYL icon
1592
Tyler Technologies
TYL
$13.1B
$2.72M ﹤0.01%
12,582
+213
+2% +$46.2K
NEU icon
1593
NewMarket
NEU
$8.38B
$2.72M ﹤0.01%
6,776
-492
-7% -$203K
FLXN
1594
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2.72M ﹤0.01%
220,899
+21,184
+11% +$244K
FIXD icon
1595
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
$2.71M ﹤0.01%
52,338
+1,751
+3% +$89.1K
TGTX icon
1596
TG Therapeutics
TGTX
$7.53B
$2.71M ﹤0.01%
313,020
-68,417
-18% -$517K
AIT icon
1597
Applied Industrial Technologies
AIT
$13.3B
$2.7M ﹤0.01%
43,949
+1,932
+5% +$113K
CQP icon
1598
Cheniere Energy
CQP
$32.3B
$2.7M ﹤0.01%
64,031
-1,127
-2% -$48K
PGF icon
1599
Invesco Financial Preferred ETF
PGF
$668M
$2.69M ﹤0.01%
146,195
+8,137
+6% +$150K
VSM
1600
DELISTED
Versum Materials, Inc.
VSM
$2.69M ﹤0.01%
52,182
-123,805
-70% -$6.39M

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.